Empire Genomics CEO Selected Fellow as Health Care Innovator for Aspen Institute

2016-07-12 20:49:27

Buffalo, NY, July 12, 2016 - Empire Genomics, LLC (, is pleased to announce the selection of Anthony Johnson, Empire Genomics’ Chief Executive Officer and President, as one of twenty-one health care leaders selected to participate in the Aspen Institute’s Health Care Innovators Fellowship Program.  The Fellowship is over the course of two years and is designed to strengthen the leadership of innovators across the US health care environment and challenge them to create new approaches that will improve the health and well-being for all Americans.

As a Health Innovator Fellow, Anthony Johnson will design and launch a leadership venture of his own choosing. The guiding purpose of this Leadership initiative is to motivate Fellows to move “from success to significance” by mobilizing their energies, their skills, and the resources at their disposal to address the foremost social, economic, and political challenges.

“I am both honored and excited to have been nominated and selected for this Fellowship Program.  I look forward to working with this group of distinguished healthcare leaders and the Aspen Institute as they continue the work of delivering healthcare improvements to my community and others across America“ says  Mr. Johnson.


About The Aspen Institute Health Innovators Fellows

The Fellowship is designed for proven, highly successful entrepreneurs and innovators in the U.S. health care field who have reached a point in their lives and careers when they are ready to use their skills and experiences to “paint on a broader canvas.” The Fellowship offers them a unique opportunity to reflect on how they can have an even greater positive impact on health care in the United States, and to connect with and learn from a diverse group of peers with whom they would not ordinarily interact. The Fellowship uses the time-tested method of text-based dialogue and building upon the Aspen Institute’s commitment to values-based, action-oriented leadership.


About Empire Genomics, LLC

Empire Genomics was created in 2006 from research started at the prestigious Roswell Park Cancer Institute in Buffalo, NY.  It is a molecular diagnostics company that develops and offers a comprehensive menu of assay services for use in diagnosing and guiding precise therapeutic treatments for patients.  The Company is committed to working with the scientific community to bring the best in genomic technologies to bear on the complex systems that biology questions.  More information can be found at


Media Contact:

Sonya Stutts